Jean-Yves Pavee, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 551 shares at $37.13 ($20K) on 2016-02-16, disclosed to the SEC on 2016-02-17.
Scheduled sale ($20k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.13 | 318 | $12K | 57.7% |
| 2 | $37.13 | 233 | $9K | 42.3% |
| Total | $37.13 avg | 551 | $20K | 100% |
| Filing → |
| ABT | SELL | 2015-03-03 | $31K | — | Filing → |
| ABT | SELL | 2015-02-18 | $29K | — | Filing → |
| ABT | SELL | 2014-02-19 | $19K | — | Filing → |